Search Tag: O3™ Regional Oximetry

ICU Management

Masimo Announces FDA 510(k) Clearance of O3™ Regional Oximetry for Pediatric Patients

2017 30 May

 Masimo (NASDAQ:MASI) announced today FDA 510(k) clearance for the pediatric indication for O3™ regional oximetry with the O3 pediatric sensor. Regional oximetry, also referred to as tissue or cerebral oximetry, may help clinicians monitor cerebral oxygenation in situations in which peripheral pulse oximetry alone may not be fully indicative of the... Read more

ICU Management

Masimo Announces the Full Market Release of Early Warning Score (EWS)

2017 19 May

Masimo Root® Patient Monitoring and Connectivity Hub with Early Warning Score (EWS)Masimo (NASDAQ: MASI) has announced the full market release of Early Warning Score (EWS) on the Root® patient monitoring and connectivity hub. EWS aggregates information from multiple vital signs and clinical observations to generate a score that represents the potential... Read more

ICU Management

DHZB Adopts Masimo’s SedLine® Brain Function Monitoring & O3™ Regional Oximetry

2016 08 Jul

Masimo (NASDAQ: MASI) has announced  that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry technologies to monitor patients in the operating room and intensive care unit.“Our non-profit hospital performs over 32,000 treatments each year.... Read more